Curless RG. Diagnostic problems in three pediatric neurology practice plans. Pediatr Neurol. 1998;19(4):272–4.

CAS  PubMed  Article  Google Scholar 

Abu-Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies. Dev Med Child Neurol. 2010;52(12):1088–97.

PubMed  Article  Google Scholar 

Hershey AD, Powers SW, Lecates S, Kabbouche MA, Maynard MK. PedMIDAS: Development of a questionnaire to assess disability of migraines in children. Neurology. 2001;57:2034–9.

CAS  PubMed  Article  Google Scholar 

Hershey AD, Powers SW, Vockell A, LeCates S, Segers A, Kabbouche M. Development of a patient-based grading scale for PedMIDAS. Cephalalgia. 2004;24(10):844–9.

CAS  PubMed  Article  Google Scholar 

Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol. 2017;16(11):877–97.

Article  Google Scholar 

•• Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. NEJM. 2017;376(2):115. (Seminal pediatric migraine trial that showed no efficacy difference between the two most commonly prescribed preventive medications and placebo••)

CAS  PubMed  Article  Google Scholar 

•• Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Prevalence of headache days and disability 3 years after participation in the Childhood and Adolescent Migraine Prevention Medication Trial. JAMA Netw Open. 2021; 10.10:1–14. CHAMP follow-up study that showed that most improvements seen after pill-based treatments are sustained long-term in children and adolescents with migraine

Sacco S, Braschinsky M, Ducros A, Lampl C, Little P, Van Den BAM, et al. European Headache Federation consensus on the definition of resistant and refractory migraine developed with the endorsement of the European Migraine & Headache Alliance (EMHA). J Headache Pain. 2020;21(1):1–12.

Article  Google Scholar 

Binder WJ, Brin MF, Blitzer A, Pogoda JM. Botulinum toxin type a (BOTOX) for treatment of migraine. Vol. 48, Disease-a-Month. 2002. p. 323–35.

Aurora SK, Aurora, Sheena K, Paul, Freeman, Marshall C, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Vol. 51, Headache. United States; 2011. p. 1358–73.

Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives NJ, et al. Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open. 2019;9(7):e027953.

PubMed  PubMed Central  Article  Google Scholar 

Barad M, Ailani J, Hakim SM, Kissoon NR, Schuster NM. Percutaneous interventional strategies for migraine prevention: a systematic review and practice guideline. Pain Med. 2022;23(1):164–88.

PubMed  Article  Google Scholar 

Blumenfeld A, Silberstein SD, Dodick DW, Aurora SK, Turkel CC, Binder WJ. Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical program. Headache. 2010;50(9):1406–18.

PubMed  Article  Google Scholar 

Marcelo R, Freund B. The efficacy of botulinum toxin in pediatric chronic migraine: a literature review. J Child Neurol. 2020;35(12):844–51.

PubMed  Article  Google Scholar 

• Winner PK, Kabbouche M, Yonker M, Wangsadipura V, Lum A, Brin MF. A randomized trial to evaluate onabotulinumtoxinA for prevention of headaches in adolescents with chronic migraine. Headache. 2020;60(3):564–75. OnabotulinumtoxinA parallel-group randomized controlled trial in children and adolescents

• Shah S, Calderon MD, Crain N, Pham J, Rinehart J. Effectiveness of onabotulinumtoxinA (BOTOX) in pediatric patients experiencing migraines: a randomized, double-blinded, placebo-controlled crossover study in the pediatric pain population. Reg Anesth Pain Med. 2021;46(1):41–8. OnabotulinumtoxinA cross-over randomized controlled trial in children and adolescents

Szperka CL, Gelfand AA, Hershey AD. Patterns of use of peripheral nerve blocks and trigger point injections for pediatric headache: results of a survey of the American Headache Society Pediatric and Adolescent Section. Headache. 2016;56(10):1597–607.

PubMed  PubMed Central  Article  Google Scholar 

Dubrovsky AS. Nerve blocks in paediatric and adolescent headache disorders. Curr Pain Headache Rep. 2017;21(50):1–6.

Google Scholar 

Gelfand AA, Reider ACGP. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol. 2014;50(2):135–9.

PubMed  Article  Google Scholar 

Lacey D. Efficacy of greater occipital nerve blocks (ONBs) in the treatment of chronic daily headaches (CDH) in adolescent females with fibromyalgia. Headache. 2008;24(3):160–77.

Article  Google Scholar 

Renaudon-Smith E, Toolis C, Goadsby P, Prabhakar P. Greater occipital nerve injection (GONI) for chronic headache in children. J Headache Pain. 2010;11(S1):1–150.

Article  Google Scholar 

Puledda F, Goadsby PJ, Prabhakar P. Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation. J Headache Pain. 2018;19:1.

Article  Google Scholar 

Esparham A, Boorigie M, Ablatt S, Connelly M, Bickel J. Improving acute treatment of pediatric primary headache disorders with a novel headache treatment center: retrospective review of preliminary outcomes. J Child Neurol. 2021;36(1):54–9.

PubMed  Article  Google Scholar 

Mousa MA, Aria DJ, Mousa AA, Schaefer CM, Temkit MH, Towbin RB. Sphenopalatine ganglion nerve block for the treatment of migraine headaches in the pediatric population. Pain Physician. 2021;24(1):E111–6.

PubMed  Google Scholar 

Kouri M, Somaini M, Cárdenas VHG, Niburski K, Vigouroux M, Ingelmo P. Transnasal sphenopalatine ganglion block for the preventive treatment of chronic daily headache in adolescents. Children. 2021;8(7):1–8.

Article  Google Scholar 

Barker T. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiol. 1991;8(1):26–37.

CAS  PubMed  Article  Google Scholar 

Brighina F, Raieli V, Messina LM, Santangelo G, Puma D, Drago F, et al. Non-invasive brain stimulation in pediatric migraine: a perspective from evidence in adult migraine. Front Neurol. 2019;10(APR):1–5.

Beaulieu LD, Schneider C. Repetitive peripheral magnetic stimulation to reduce pain or improve sensorimotor impairments: a literature review on parameters of application and afferents recruitment. Neurophysiol Clinlinique. 2015;45(3):223–37.

Article  Google Scholar 

Rossini PM, Burke D, Chen R, Cohen LG, Daskalakis Z, Di Iorio R, et al. Non-invasive electrical and magnetic stimulation of the brain spinal cord roots and peripheral nerves basic principles and procedures for routine clinical and research application An updated report from an I.F.C.N. Committee. Clin Neurophysiol. 2015;126(6):1071–107.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gilbert DL, Garvey MA, Bansal AS, Lipps T, Zhang J, Wassermann EM. Should transcranial magnetic stimulation research in children be considered minimal risk? Clin Neurophysiol. 2004;115(8):1730–9.

PubMed  Article  Google Scholar 

Krishnan C, Santos L, Peterson MD, Ehinger M. Safety of noninvasive brain stimulation in children and adolescents. Brain Stimuls. 2015;8(1):76–87.

Article  Google Scholar 

Zewdie E, Ciechanski P, Kuo HC, Giuffre A, Kahl C, King R, et al. Safety and tolerability of transcranial magnetic and direct current stimulation in children: prospective single center evidence from 3.5 million stimulations. Brain Stimul. 2020;13(3):565–75.

• Irwin SL, Qubty W, Allen IE, Patniyot I, Goadsby PJ, Gelfand AA. Transcranial magnetic stimulation for migraine prevention in adolescents: a pilot open-label study. Headache. 2018;58(5):724–31. Transcranial magnetic stimulation open-label pilot study among children and adolescents with migraine

Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010;9(4):373–80.

PubMed  Article  Google Scholar 

Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hindiyeh N, et al. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia. 2018;38(6):1038–48.

PubMed  PubMed Central  Article  Google Scholar 

Schoenen JE, Vandersmissen B, Herroelen L, Vandenheede M, Gerard P, Magis D. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013;80:697–704.

PubMed  Article  Google Scholar 

Chou DE, Shnayderman Yugrakh M, Winegarner D, Rowe V, Kuruvilla D, Schoenen J. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trial. Cephalalgia. 2019;39(1):3–14.

PubMed  Article  Google Scholar 

Hokenek NM, Erdogan MO, Hokenek UD, Algin A, Tekyol D, Seyhan AU. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: a randomized controlled trial. Am J Emerg Med. 2021;39:80–5.

PubMed  Article  Google Scholar 

Kuruvilla DE, Mann JI, Tepper SJ, Starling AJ, Panza G, Johnson MAL. Phase 3 randomized, double-blind, sham-controlled Trial of e-TNS for the Acute treatment of Migraine (TEAM). Sci Rep. 2022;12(1):1–11.

Article  CAS  Google Scholar 

Vikelis M, Dermitzakis EV, Spingos KC, Vasiliadis GG, Vlachos GS, Kararizou E. Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study. BMC Neurol. 2017;17(1):1–7.

Article  CAS  Google Scholar 

Jiang L, Yuan D, Li M, Liu C, Liu Q, Zhang Y, et al. Combination of flunarizine and transcutaneous supraorbital neurostimulation improves migraine prophylaxis. Act Neurol Scand. 2019;139(3). https://doi.org/10.1111/ane.13050

Magis D, Magis, Delphine, Sava, Simona, d’Elia, et al. Safety and patients’ satisfaction of transcutaneous supraorbital neurostimulation (tSNS) with the Cefaly device in headache treatment: a survey of 2,313 headache sufferers in the general population. Vol. 14, Journal of Headache & Pain. Italy; 2013. p. 95-.

Di Fiore P, Bussone G, Galli A, Didier H, Peccarisi C, D’Amico D, et al. Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial. Neurol Sci. 2017;38:201–6.

PubMed  Article  Google Scholar 

Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, et al. Remote electrical neuromodulation (REN) relieves acute migraine: a randomized, double-blind, placebo-controlled, multicenter trial. Headache. 2019;59(8):1240–52.

PubMed  PubMed Central  Article  Google Scholar 

•• Hershey AD, Lin T, Gruper Y, Harris D, Ironi A, Thomas M, et al. Remote electrical neuromodulation for acute treatment of migraine in adolescents. Headache. 2021;61(2):310–7. Remote electrical neuromodulation open-label trial study among children and adolescents with migraine

Yarnitsky D, Volokh L, Ironi A, Weller B, Shor M, Shifrin A, et al. Nonpainful remote electrical stimulation alleviates episodic migraine pain. Neurology. 2017;88(13):1250–5.

PubMed  Article  Google Scholar 

Marmura MJ, Lin T, Harris D, Ironi A, Rosen NL. Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: an open-label extension study. Front Neurol. 2020;11(April):1–8.

Google Scholar 

Buse D, Rabany L, Lin T, Ironi A, Connelly M, Bickel J. Combining guided intervention of education and relaxation (GIER) with remote electrical neuromodulation (REN) in the acute treatment of migraine. Pain Med. 2022. https://doi.org/10.1093/pm/pnac021.

Article  PubMed  Google Scholar 

Vecchio E, Bassez I, Ricci K, Tassorelli C, Liebler E, de Tommaso M. Effect of non-invasive vagus nerve stimulation on resting-state electroencephalography and laser-evoked potentials in migraine patients: mechanistic insights. Front Hum Neurosci. 2018. https://doi.org/10.3389/fnhum.2018.00366.

Article  PubMed  PubMed Central  Google Scholar 

• Grazzi L, Egeo G, Liebler E, Padovan A, Barbanti P. Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study. Neurol Sci. 2017;38(S1):S197–99. Non-invasive vagal nerve stimulation open-label pilot study among children and adolescents with migraine

Tassorelli C, Grazzi L, De Tommaso M, Pierangeli G, Martelletti P, Rainero I, et al. Noninvasive vagus nerve stimulation as acute therapy for migraine: the randomized PRESTO study. Neurology. 2018;91(4):e364–73.